|
Omar Abdel-Rahman
|
June 2020 |
Impact of Baseline Characteristics on Extensive-stage SCLC Patients Treated with Etoposide/Carboplatin; a Secondary Analysis of a Phase III Study |
The Clinical Respiratory Journal |
|
G. Sonpavde, G. R. Pond, A. J. Templeton, E. D. Kwon, J.S. De Bono
|
June 2020 |
Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer |
Prostate Cancer and Prostatic Diseases |
|
Theresa Wizemann, Eeshan Khandekar, Jennifer Hinners, Carolyn Shore
|
July 2020 |
Reflections on Sharing Clinical Trial Data: Challenges and a Way Forward: Proceedings of a Workshop (2020) |
National Academies Press |
|
Hirotaka Miyashita, Christina Cruz, Cardinale Smith
|
August 2020 |
Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate—a post hoc analysis of a randomized clinical trial |
Supportive Care in Cancer |
|
Sophia Z. Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David M. Miller
|
September 2020 |
Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis |
Case Reports in Oncological Medicine |
|
Farees Saqlain, Sophia Z. Shalhout, Kevin S. Emerick, Tomas G. Neilan, Tatyana Sharova, David Michael Miller
|
September 2020 |
Metastatic Merkel Cell Carcinoma Masquerading as Multiple Immune-Related Adverse Events |
Case Reports in Dermatological Medicine |
|
Aurélie Lombard, Hitesh Mistry, Leon Aarons, Kayode Ogungbenro
|
October 2020 |
Dose individualisation in oncology using chemotherapy‐induced neutropenia: Example of docetaxel in non‐small cell lung cancer patients |
British Journal of Clinical Pharmacology |
|
Khaled El Emam, Lucy Mosquera, Chaoyi Zheng
|
November 2020 |
Optimizing the synthesis of clinical trial data using sequential trees |
Journal of the American Medical Informatics Association |
|
Steven B.Cohen, Jennifer Unangst, Feng Yu
|
November 2020 |
Enhancing the analytic utility of clinical trial data to inform health disparities research |
Contemporary Clinical Trials Communications |
|
Krastan B. Blagoev, Roumen Iordanov, Mengxi Zhou, Tito Fojo, Susan E. Bates
|
January 2021 |
Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer |
Oncotarget |
|
Lixia Wu, Lina Zhu, Kequn Xu, Siyuan Zhou, Yang Zhou, Tiening Zhang, Junjie Hang, Benny Chung-Ying Zee
|
January 2021 |
Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data |
Journal of Cancer |
|
Sophia Z.Shalhout, PhD; Jong ChulPark, MD; Kevin S.Emerick,MD; Ryan J.Sullivan, MD; Howard L.Kaufman, MD; David M.MillerMD, PhD
|
January 2021 |
Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma |
Journal of the American Academy of Dermatology |
|
Alberto Martini, Anish B. Parikh, John P. Sfakianos, Francesco Montorsi, Matthew D. Galsky, William K. Oh, Che-Kai Tsao
|
February 2021 |
Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data |
Prostate Cancer and Prostatic Diseases |
|
Jiawei Zhou, Quefeng Li, Yanguang Cao
|
February 2021 |
Spatiotemporal Heterogeneity Across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer |
Cancer Research |
